ORAXION THERAPEUTICS

Oraxion Therapeutics is a drug discovery company focused on rare and orphan diseases. A rare disease is defined as one that affects less than 1 in 2000 patients. There are an estimated 7000 distinct rare diseases known with a global population of ~350 million patients. USA is expected to have ~30 million patients, while India is expected to have ~70 million patients suffering from rare diseases. Fewer than 5% of these diseases have therapeutic alternatives available. More than 80% of these diseases have a genetic origin while almost 50% of them primarily affect children.